Sana Biotechnology SANA Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's other intangible assets—net?
- Sana Biotechnology (SANA) reported other intangible assets—net of $59.2M in Q1 2026.
- How has Sana Biotechnology's other intangible assets—net changed year-over-year?
- Sana Biotechnology's other intangible assets—net decreased by 0.0% year-over-year, from $59.2M to $59.2M.
- What is the long-term trend for Sana Biotechnology's other intangible assets—net?
- Over 5 years (2020 to 2025), Sana Biotechnology's other intangible assets—net has grown at a 0.0% compound annual growth rate (CAGR), from $59.2M to $59.2M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.